Authors:
GEHLING UM
RYDER JW
HOGAN CJ
HAMI L
MCNIECE I
FRANKLIN W
WILLIAMS S
HELM K
KING J
SHPALL EJ
Citation: Um. Gehling et al., EFFECTS OF VARIOUS GROWTH-FACTOR COMBINATIONS ON THE EX-VIVO EXPANSION OF HUMAN MEGAKARYOCYTE (MK) PROGENITORS, Thrombosis and haemostasis, 1997, pp. 19-19
Authors:
GEHLING UM
RYDER JW
HOGAN CJ
HAMI L
MCNIECE I
FRANKLIN W
WILLIAMS S
HELM K
KING J
SHPALL EJ
Citation: Um. Gehling et al., EX-VIVO EXPANSION OF MEGAKARYOCYTE PROGENITORS - EFFECT OF VARIOUS GROWTH-FACTOR COMBINATIONS ON CD34(-MARROW AND G-CSF-MOBILIZED PERIPHERAL-BLOOD() PROGENITOR CELLS FROM BONE), Experimental hematology, 25(11), 1997, pp. 1125-1139
Authors:
ZUMERCHIK P
GREER G
HAMI L
SHPALL EJ
GREEN T
GOODRICH R
Citation: P. Zumerchik et al., EVALUATION OF THE SIZE AND DENSITY CHARACTERISTICS OF NON-MOBILIZED AND MOBILIZED WHITE CELL SAMPLES FROM WHOLE-BLOOD AND PBSC APHERESIS PRODUCTS, Blood, 90(10), 1997, pp. 4319-4319
Authors:
GREER G
HAMI L
ZUMERCHIK P
GREEN T
GOODRICH R
SHPALL EJ
Citation: G. Greer et al., VIABILITY AND RECOVERY OF PBSC PRODUCTS STORED AT ROOM-TEMPERATURE ISDEPENDENT ON STORAGE-CONDITIONS, Blood, 90(10), 1997, pp. 920-920
Authors:
PUGH RE
BITTER MA
HAMI L
SHPALL EJ
FRANKLIN WA
Citation: Re. Pugh et al., CD19 COLUMN PRESELECTION INCREASES SENSITIVITY OF LYMPHOMA CELL DETECTION BY PCR FOR THE T(14-18) BREAKPOINT, The FASEB journal, 10(6), 1996, pp. 775-775
Authors:
STEMMER SM
CAGNONI PJ
SHPALL EJ
BEARMAN SI
MATTHES S
DUFTON C
DAY T
TAFFS S
HAMI L
MARTINEZ C
PURDY MH
ARRON J
JONES RB
Citation: Sm. Stemmer et al., HIGH-DOSE PACLITAXEL, CYCLOPHOSPHAMIDE, AND CISPLATIN WITH AUTOLOGOUSHEMATOPOIETIC PROGENITOR-CELL SUPPORT - A PHASE-I TRIAL, Journal of clinical oncology, 14(5), 1996, pp. 1463-1472
Authors:
FRANKLIN WA
SHPALL EJ
ARCHER P
JOHNSTON CS
GARZAWILLIAMS S
HAMI L
BITTER MA
BAST RC
JONES RB
Citation: Wa. Franklin et al., IMMUNOCYTOCHEMICAL DETECTION OF BREAST-CANCER CELLS IN MARROW AND PERIPHERAL-BLOOD OF PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT, Breast cancer research and treatment, 41(1), 1996, pp. 1-13
Authors:
LAYTON TJ
OSTRANDER AB
KENNEDY MJ
SHPALL EJ
JONES RB
HAMI L
ROSS AA
Citation: Tj. Layton et al., ENHANCED DETECTION OF BREAST-TUMOR CELLS BY IMMUNOCHEMISTRY FOLLOWINGENRICHMENT USING AN AVIDIN AFFINITY COLUMN, Blood, 88(10), 1996, pp. 3648-3648
Authors:
GREER G
FRANKLIN W
HAMI L
WILLIAMS S
JONES K
STOLZ J
EMMERMAN J
SHPALL E
Citation: G. Greer et al., A CLONOGENIC CULTURE METHOD FOR THE IDENTIFICATION OF BREAST-CANCER CELLS IN MARROW ASPIRATES OF PATIENTS RECEIVING HIGH-DOSE CHEMOTHERAPY, Blood, 88(10), 1996, pp. 996-996
Authors:
HOGAN C
SHPALL E
HELM K
HAMI L
MCNIECE I
KELLER G
Citation: C. Hogan et al., ENGRAFTMENT AND DEVELOPMENT OF HUMAN CD34(-ENRICHED CELLS FROM G-MOBILIZED PERIPHERAL-BLOOD IN NOD())LTSZ-SCID/SCID (NOD/SCID) MICE/, Blood, 88(10), 1996, pp. 2379-2379
Authors:
SHPALL EJ
SANFORD C
HAMI L
FELT T
BEARMAN S
CAGNONI PJ
ROSS M
SCHRAMM K
VEREERSTRAETEN M
PAPROCKI J
JONES RB
Citation: Ej. Shpall et al., A RANDOMIZED STUDY OF THE STANDARD VERSUS A NEW AUTOMATED LEUKAPHERESIS PROCEDURE USING THE COBE SPECTRA(TM), Blood, 88(10), 1996, pp. 2558-2558
Authors:
GEHLING U
RYDER J
HAMI L
HOGAN CJ
MCNIECE I
SHIEH JH
GRINGERI A
FRANKLIN W
WILLIAMS S
KING J
MCBURNIE E
SHPALL EJ
Citation: U. Gehling et al., EX-VIVO EXPANSION OF MEGAKARYOCYTE (MK) PROGENITORS USING RECOMBINANTHUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (MGDF-B) IN VARIOUSGROWTH-FACTOR COMBINATIONS, Blood, 86(10), 1995, pp. 442-442
Authors:
CAGNONI PJ
JONES RB
FRANKLIN W
HAMI L
BERENSON RJ
JACOBS C
ROSS M
BEARMAN SI
SHPALL EJ
Citation: Pj. Cagnoni et al., USE OF CD34 POSITIVE AUTOLOGOUS HEMATOPOIETIC PROGENITORS TO SUPPORT PATIENTS WITH BREAST-CANCER AFTER HIGH-DOSE CHEMOTHERAPY, Blood, 86(10), 1995, pp. 1533-1533
Authors:
KELLER G
HOGAN C
MCBURNEY E
HAMI L
HELM K
SHULTZ L
DICK J
MCNIECE I
SHPALL E
Citation: G. Keller et al., TRANSPLANTATION OF CD34(-CORD BLOOD PROGENITOR CELLS INTO NONOBESE DIABETIC (NOD)() HUMAN (HU) UMBILICAL)SEVERS COMBINED IMMUNODEFICIENCY (SCID) MICE/, Blood, 86(10), 1995, pp. 2278-2278
Authors:
SHPALL EJ
JONES RB
BEARMAN SI
FRANKLIN WA
ARCHER PG
CURIEL T
BITTER M
CLAMAN HN
STEMMER SM
PURDY M
MYERS SE
HAMI L
TAFFS S
HEIMFELD S
HALLAGAN J
BERENSON RJ
Citation: Ej. Shpall et al., TRANSPLANTATION OF ENRICHED CD34-POSITIVE AUTOLOGOUS MARROW INTO BREAST-CANCER PATIENTS FOLLOWING HIGH-DOSE CHEMOTHERAPY - INFLUENCE OF CD34-POSITIVE PERIPHERAL-BLOOD PROGENITORS AND GROWTH-FACTORS ON ENGRAFTMENT, Journal of clinical oncology, 12(1), 1994, pp. 28-36
Authors:
SHPALL EJ
STEMMER SM
HAMI L
FRANKLIN WA
SHAW L
BONNER HS
BEARMAN SI
PETERS WP
BAST RC
MCCULLOCH W
CAPIZZI R
MITCHELL E
SCHEIN PS
JONES RB
Citation: Ej. Shpall et al., AMIFOSTINE (WR-2721) SHORTENS THE ENGRAFTMENT PERIOD OF 4-HYDROPEROXYCYCLOPHOSPHAMIDE-PURGED BONE-MARROW IN BREAST-CANCER PATIENTS RECEIVING HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW SUPPORT, Blood, 83(11), 1994, pp. 3132-3137